| Rachel Stoller, MS CCC-SLP | |
|
1000 Providence Dr, Newberg, OR 97132-7485 | |
| (503) 537-1863 | |
| Not Available |
| Full Name | Rachel Stoller |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1000 Providence Dr, Newberg, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235517319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 15482 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Stoller, MS CCC-SLP 1000 Providence Dr Ste 220, Newberg, OR 97132-7485 Ph: (503) 537-1863 | Rachel Stoller, MS CCC-SLP 1000 Providence Dr, Newberg, OR 97132-7485 Ph: (503) 537-1863 |
News Archive
The health of blood cells' energy-producing mitochondria may predict a person's risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
A Journal of the American Geriatrics Society study found that in men aged 65 and older who survived an ischemic stroke, the lack of an available caregiver was associated with triple the risk of nursing home placement within five years. A similar risk was not seen in women.
NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.
Researchers at the Jules Bordet Institute - Université libre de Bruxelles, VIB and KU Leuven published this 21 of April an important study offering a better understanding of the progression of breast cancer.
ENTEROME Bioscience SA, a pioneer in the development of therapeutic solutions (drugs and diagnostics) based on a thorough understanding of the gut microbiome, announces that it has entered into a collaborative development agreement with AbbVie.
› Verified 7 days ago
Mrs. Trinity Deibert, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1515 Portland Rd, Suite 102, Newberg, OR 97132 Phone: 503-572-3953 Fax: 503-537-1888 | |
H.e.a.r.t. Institute West Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 N Meridian St Ste B, Newberg, OR 97132 Phone: 503-901-5652 | |
Heart To Heart Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 N Meridian St, Suite B, Newberg, OR 97132 Phone: 503-901-5652 Fax: 888-587-8510 | |
Smart Mouth Slp Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 N Brutscher St # D113, Newberg, OR 97132 Phone: 503-440-0399 | |
Laura Michelle Donart, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 310 Villa Rd Ste 101, Newberg, OR 97132 Phone: 503-537-3546 | |
Casandra Nicole Glatz, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Villa Rd, Newberg, OR 97132 Phone: 503-537-3546 |